Trial
NCT01184053
Trisenox® in Women With Metastatic Endometrial Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
UNC Lineberger Comprehensive Cancer Center
Collaborators
Cephalon
Condition
Endometrial Carcinoma
Intervention
Arsenic trioxide
Why stopped
Accrual was very low. No subject had been enrolled in a year.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-06-14